(1)
THE IMPACT OF TERLIPRESSIN ON HEPATORENEAL DISEASE: RESULTS OF AN OBSERVATIONAL, DESCRIPTIVE, AND CROSS-SECTIONAL STUDY DISEASE. Journal of Pharmaceutical Negative Results 2022, 2320-2326.